1
|
Heusschen L, Krabbendam I, van der Velde JM, Deden LN, Aarts EO, Merién AER, Emous M, Bleumink GS, Lutgers HL, Hazebroek EJ. A Matter of Timing-Pregnancy After Bariatric Surgery. Obes Surg 2021; 31:2072-2079. [PMID: 33432482 PMCID: PMC8041698 DOI: 10.1007/s11695-020-05219-3] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Revised: 12/31/2020] [Accepted: 12/31/2020] [Indexed: 12/30/2022]
Abstract
PURPOSE Current guidelines recommend to avoid pregnancy for 12-24 months after bariatric surgery because of active weight loss and an increased risk of nutritional deficiencies. However, high-quality evidence is lacking, and only a few studies included data on gestational weight gain. We therefore evaluated pregnancy and neonatal outcomes by both surgery-to-conception interval and gestational weight gain. MATERIALS AND METHODS A multicenter retrospective analysis of 196 singleton pregnancies following Roux-en-Y gastric bypass, sleeve gastrectomy, and one anastomosis gastric bypass was conducted. Pregnancies were divided into the early group (≤ 12 months), the middle group (12-24 months), and the late group (> 24 months) according to the surgery-to-conception interval. Gestational weight gain was classified as inadequate, adequate, or excessive according to the National Academy of Medicine recommendations. RESULTS Pregnancy in the early group (23.5%) was associated with lower gestational age at delivery (267.1 ± 19.9 days vs 272.7 ± 9.2 and 273.1 ± 13.5 days, P = 0.029), lower gestational weight gain (- 0.9 ± 11.0 kg vs + 10.2 ± 5.6 and + 10.0 ± 6.4 kg, P < 0.001), and lower neonatal birth weight (2979 ± 470 g vs 3161 ± 481 and 3211 ± 465 g, P = 0.008) than pregnancy in the middle and late group. Inadequate gestational weight gain (40.6%) was associated with lower gestational age at delivery (266.5 ± 20.2 days vs 273.8 ± 8.4 days, P = 0.002) and lower neonatal birth weight (3061 ± 511 g vs 3217 ± 479 g, P = 0.053) compared to adequate weight gain. Preterm births were also more frequently observed in this group (15.9% vs 6.0%, P = 0.037). CONCLUSION Our findings support the recommendation to avoid pregnancy for 12 months after bariatric surgery. Specific attention is needed on achieving adequate gestational weight gain.
Collapse
Affiliation(s)
- Laura Heusschen
- Department of Bariatric Surgery, Vitalys, part of Rijnstate hospital, Postal number 1191, PO box 9555, 6800TA, Arnhem, The Netherlands.
- Divison of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands.
| | - Ineke Krabbendam
- Department of Obstetrics and Gynecology, Hospital Gelderse Vallei, Ede, The Netherlands
| | | | - Laura N Deden
- Department of Bariatric Surgery, Vitalys, part of Rijnstate hospital, Postal number 1191, PO box 9555, 6800TA, Arnhem, The Netherlands
| | - Edo O Aarts
- Department of Bariatric Surgery, Vitalys, part of Rijnstate hospital, Postal number 1191, PO box 9555, 6800TA, Arnhem, The Netherlands
| | - Ashley E R Merién
- Department of Obstetrics and Gynecology, Rijnstate hospital, Arnhem, The Netherlands
| | - Marloes Emous
- Center of Obesity the Northern Netherlands, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
| | - Gysèle S Bleumink
- Department of Internal Medicine, Rijnstate hospital, Arnhem, The Netherlands
| | - Helen L Lutgers
- Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands
| | - Eric J Hazebroek
- Department of Bariatric Surgery, Vitalys, part of Rijnstate hospital, Postal number 1191, PO box 9555, 6800TA, Arnhem, The Netherlands
- Divison of Human Nutrition and Health, Wageningen University, Wageningen, The Netherlands
| |
Collapse
|
2
|
Roos C, Schuit E, Scheepers HCJ, Bloemenkamp KWM, Bolte AC, Duvekot HJJ, van Eyck J, Kok JH, Kwee A, Merién AER, Opmeer BC, Oudijk MA, van Pampus MG, Papatsonis DNM, Porath MM, Sollie KM, Spaanderman MEA, Vijgen SMC, Willekes C, Lotgering FK, van der Post JAM, Mol BWJ. Predictive Factors for Delivery within 7 Days after Successful 48-Hour Treatment of Threatened Preterm Labor. AJP Rep 2015; 5:e141-9. [PMID: 26495173 PMCID: PMC4603845 DOI: 10.1055/s-0035-1552930] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2014] [Accepted: 03/25/2015] [Indexed: 10/26/2022] Open
Abstract
Objective The aim of this study was to assess which characteristics and results of vaginal examination are predictive for delivery within 7 days, in women with threatened preterm labor after initial treatment. Study Design A secondary analysis of a randomized controlled trial on maintenance nifedipine includes women who remained undelivered after threatened preterm labor for 48 hours. We developed one model for women with premature prelabor rupture of membranes (PPROM) and one without PPROM. The predictors were identified by backward selection. We assessed calibration and discrimination and used bootstrapping techniques to correct for potential overfitting. Results For women with PPROM (model 1), nulliparity, history of preterm birth, and vaginal bleeding were included in the multivariable analysis. For women without PPROM (model 2), maternal age, vaginal bleeding, cervical length, and fetal fibronectin (fFN) status were in the multivariable analysis. Discriminative capability was moderate to good (c-statistic 0.68; 95% confidence interval [CI] 0.60-0.77 for model 1 and 0.89; 95% CI, 0.84-0.93 for model 2). Conclusion PPROM and vaginal bleeding in the current pregnancy are relevant predictive factors in all women, as are maternal age, cervical length, and fFN in women without PPROM and nulliparity, history of preterm birth in women with PPROM.
Collapse
Affiliation(s)
- Carolien Roos
- Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Ewoud Schuit
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Hubertina C J Scheepers
- Department of Obstetrics and Gynecology, Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands
| | - Kitty W M Bloemenkamp
- Department of Obstetrics and Gynecology, Leiden University Medical Center, Leiden, The Netherlands
| | - Antoinette C Bolte
- Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Hans J J Duvekot
- Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, The Netherlands
| | - Jim van Eyck
- Department of Obstetrics and Gynecology, Isala Clinics, Zwolle, The Netherlands
| | - Joke H Kok
- Department of Neonatology, Academic Medical Center, Amsterdam, The Netherlands
| | - Anneke Kwee
- Department of Obstetrics and Gynecology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Ashley E R Merién
- Department of Obstetrics and Gynecology, Ziekenhuis Rijnstate, Arnhem, The Netherlands
| | - Brent C Opmeer
- Clinical Research Unit, Academic Medical Center, Amsterdam, The Netherlands
| | - Martijn A Oudijk
- Department of Obstetrics and Gynecology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - Mariëlle G van Pampus
- Department of Obstetrics and Gynecology, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands
| | | | - Martina M Porath
- Department of Obstetrics and Gynecology, Máxima Medical Center, Veldhoven, The Netherlands
| | - Krystyna M Sollie
- Department of Obstetrics and Gynecology, University Medical Center, Groningen, The Netherlands
| | - Marc E A Spaanderman
- Department of Obstetrics and Gynecology, Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands
| | | | - Christine Willekes
- Department of Obstetrics and Gynecology, Maastricht University Medical Center, GROW School for Oncology and Developmental Biology, Maastricht, The Netherlands
| | - Fred K Lotgering
- Department of Obstetrics and Gynecology, Radboud University Medical Center, Nijmegen, The Netherlands
| | - Joris A M van der Post
- Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam, The Netherlands
| | - Ben Willem J Mol
- The Robinson Institute, School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, Australia
| | | |
Collapse
|